Impact of Sugammadex vs. Neostigmine Reversal on Post-Operative Recovery and Complications (Sugammadex)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03679611 |
|
Recruitment Status :
Completed
First Posted : September 20, 2018
Last Update Posted : October 14, 2022
|
Sponsor:
University Health Network, Toronto
Collaborator:
Merck Canada Inc.
Information provided by (Responsible Party):
Jean Wong, University Health Network, Toronto
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | October 26, 2021 |
| Actual Study Completion Date : | October 26, 2021 |